Tango Therapeutics, Inc. · NASDAQ:TNGX
Adage Capital Management, L.P. reported a 8.98% stake in Tango Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 13, 2026
Adage Capital Management, L.P. reported a 8.98% stake in Tango Therapeutics, Inc., 12,809,485 shares, as a passive investor on Mar 31, 2026. Filed May 13, 2026 (Schedule 13G/A).
- Stake
- 8.98%
- Shares
- 12,809,485
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 8.98% | 12,809,485 |
| Robert Atchinson | 8.98% | 12,809,485 |
| Phillip Gross | 8.98% | 12,809,485 |
Source
Related
- Tango Therapeutics, Inc.
- Adage Capital Management, L.P.
- Tango Therapeutics, Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G · Adage Capital Management, L.P. · Feb 12, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Nov 13, 2025
- Schedule 13G · Adage Capital Management, L.P. · Aug 12, 2025
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026